tiprankstipranks
Royalty Pharma PLC (RPRX)
NASDAQ:RPRX
Holding RPRX?
Track your performance easily

Royalty Pharma (RPRX) Technical Analysis

1,215 Followers

Technical Sentiment

Overall Consensus
Strong Sell
3Bullish
5Neutral
14Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Royalty Pharma PLC’s (RPRX) Moving Averages Convergence Divergence (MACD) indicator is -0.15, suggesting Royalty Pharma PLC is a Sell.
Royalty Pharma PLC’s (RPRX) 20-Day exponential moving average is 26.30, while Royalty Pharma PLC’s (RPRX) share price is $25.59, making it a Sell.
Royalty Pharma PLC’s (RPRX) 50-Day exponential moving average is 26.66, while Royalty Pharma PLC’s (RPRX) share price is $25.59, making it a Sell.

Royalty Pharma (RPRX) Pivot Points

Dec 22, 2024, 12:23 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
24.94
25.40
25.66
26.12
26.38
26.84
27.10
Fibonacci
25.40
25.68
25.85
26.12
26.40
26.57
26.84
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Royalty Pharma (RPRX) Moving Averages

Dec 22, 2024, 12:23 PM
Period
Simple
Exponential
MA5
26.15Sell
26.13Sell
MA10
26.32Sell
26.21Sell
MA20
26.13Sell
26.30Sell
MA50
26.82Sell
26.66Sell
MA100
27.25Sell
26.96Sell
MA200
27.43Sell
27.31Sell
Royalty Pharma PLC’s (RPRX) 10-Day exponential moving average is 26.21, while Royalty Pharma PLC’s (RPRX) share price is $25.59, making it a Sell.
Royalty Pharma PLC’s (RPRX) 100-Day exponential moving average is 26.96, while Royalty Pharma PLC’s (RPRX) share price is $25.59, making it a Sell.
Royalty Pharma PLC’s (RPRX) stock price is $25.59 and Royalty Pharma PLC’s (RPRX) 50-day simple moving average is 26.82, creating a Sell signal.
Royalty Pharma PLC’s (RPRX) stock price is $25.59 and Royalty Pharma PLC’s (RPRX) 100-day simple moving average is 27.25, creating a Sell signal.
Royalty Pharma PLC’s (RPRX) stock price is $25.59 and Royalty Pharma PLC’s (RPRX) 200-day simple moving average is 27.43, creating a Sell signal.

Royalty Pharma (RPRX) Technical Indicators

Dec 22, 2024, 12:23 PM
Name
Value
Implied Action
RSI (14)
43.04
Neutral
STOCH (9,6)
30.74
Neutral
STOCHRSI (14)
48.88
Neutral
MACD (12,26)
-0.15
Sell
ADX (14)
14.84
Buy
Williams %R
-60.29
Buy
CCI (14)
-51.84
Neutral
ATR (14)
0.51
-
Ultimate Oscillator
45.65
Neutral
ROC
0.81
Buy
Royalty Pharma PLC’s (RPRX) Relative Strength Index (RSI) is 43.04, creating a Neutral signal.
Royalty Pharma PLC’s (RPRX) Trend Strength Indicator (ADX) is 14.84, creating a Buy signal.
Royalty Pharma PLC’s (RPRX) Commodity Channel Index (CCI) is -51.84, creating a Neutral signal.
Royalty Pharma PLC’s (RPRX) Price Rate of Change (ROC) is 0.81, creating a Buy signal.

FAQ

Is RPRX a Buy, Hold, or Sell?
Based on RPRX’s technical indicators, RPRX is a Strong Sell.
    What is RPRX’s RSI (14)?
    RPRX’s RSI (14) is 43.04, which suggests RPRX is a Neutral.
      What is RPRX’s MACD?
      RPRX’s MACD is -0.15, which suggests RPRX is a Sell.
        What is RPRX’s 5-day moving average?
        RPRX’s 5-day moving average is 26.15, which suggests RPRX is a Sell.
          What is RPRX’s 20-day moving average?
          RPRX 20-day moving average is 26.13, which suggests RPRX is a Sell.
            What is RPRX’s 50-day moving average?
            RPRX’s 50-day moving average is 26.82, which suggests RPRX is a Sell.
              What is RPRX’s 200-day moving average?
              RPRX’s 200-day moving average is 27.43, which suggests RPRX is a Sell.
                What is RPRX’s Williams % R (14)?
                RPRX’s Williams % R (14) is -60.29, which suggests RPRX is a Buy.
                  What is RPRX’s CCI (14)?
                  RPRX’s CCI (14) is -51.84, which suggests RPRX is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis